PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-01

Date Title Company
01-Dec-2022 SpectrumX’s Hand Sanitiser Approved for NHS Supply Chain’s NHS Supplier List Businesswire
01-Dec-2022 AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases Businesswire
01-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Dec-2022 ViiV Healthcare unveils a new global study revealing three quarters of people believe there are still negative perceptions when it comes to people living with HIV ViiV Healthcare
01-Dec-2022 Nass Valley Gardens Announces It Has Contracted Its Reg A+ Capital Raise Team Nass Valley Gateway Ltd.
01-Dec-2022 Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups Andrew Lloyd Associates
01-Dec-2022 Adocia Strengthens Its Cash Position with EUR 6 Million Through the Issuance of Convertible Bonds Subscribed by European Investors in Order to Accelerate the Development of Key Products Businesswire
01-Dec-2022 Change in the Management of CHEPLAPHARM Cheplapharm AG
01-Dec-2022 Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology Avectas
01-Dec-2022 RetinAI launches Discovery CORE™: an AI-powered, collaborative platform to accelerate Clinical and Academic Research, and RWE analysis in ophthalmology RetinAI
01-Dec-2022 Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process Creative Proteomics
01-Dec-2022 Creative Proteomics Lipidomics Launches Ceramides Analysis Service Creative Proteomics
01-Dec-2022 Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service Creative Proteomics
01-Dec-2022 BRIM Biotechnology, Inc. raises $20 million in Series E funding round Sciad Newswire
01-Dec-2022 BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT Biophytis
01-Dec-2022 Portfolio company Lysatpharma and joint venture Novaxomx start with research and product development in biosurgical treatment therapies Xlife Sciences AG
01-Dec-2022 Regenerative Artificial Skin Market to grow at a rate of 9.9% between 2022 and 2032 | Get Insights FMI MARKITWIRED
01-Dec-2022 Quadriplegia Treatment Market is projected to expand at a CAGR of 4.7% and gain a revenue worth US$ 2,324.4 Mn by 2032-End MARKITWIRED
01-Dec-2022 Ophthalmic Lasers Market is projected to increase from a valuation of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030 | Future Market Insights MARKITWIRED
01-Dec-2022 Coronary Stents Market to Reach a Revenue of US$ 51.2 Mn During the Forecast Period of 2022-32 | Future Market Insights, Inc. MARKITWIRED